Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Luka Levata

Luka Levata

Center of Brain, Behavior and Metabolism (CBBM), Germany

Title: Centrally acting nesfatin-1 induces non-shivering thermogenesis in Brown Adipose Tissue (BAT) via the melanocortin pathway

Biography

Biography: Luka Levata

Abstract

Nesfatin-1 is an anorexigenic peptide expressed both in adipose depots and hypothalamic nuclei that regulate food consumption. Recently, our group has reported that centrally administered nesfatin-1 also increases overall energy expenditure. We thus performed a study, using Wistar rats and C57BL/6 mice to examine if centrally acting nesfatin-1 employs the melanocortin system toward energy homeostasis, and elicits sympathetic outflow to interscapular brown adipose tissue (iBAT) to initiate thermogenesis. Healthy male animals of both species were stereotaxically implanted with intracerebroventricular cannula to receive central injections. First, with the application of direct calorimetry, we demonstrated that in rats nesfatin-1 [25 pmol] elicits a substantial increase in dry heat loss that lasts for 7 hours (p<0.01). This effect was fully precluded (p<0.01) by the co-administration with an equimolar dose of SHU9119, a potent MC3/4 receptor antagonist. The RT-PCR analysis showed that centrally administered nesfatin-1 [100 pmol] promoted POMC and MC3 receptor mRNA expression (p<0.01) in the hypothalamus and, as a trend, also of MC4 receptor mRNA. This was accompanied by increased DIO2 mRNA expression (p<0.01) and trend of increase in UCP1 and PGC-1α mRNA in iBAT. Moreover, the assessment with infrared thermography revealed that centrally delivered nesfatin-1 [300 pmol] in mice enhances (p<0.01) iBAT, as well as ocular surface temperature (p<0.05). We also demonstrated that this effect is completely abolished (p<0.01) when administered in pair with SR59230A [5 mg/kg], a potent and highly selective β3-adrenoceptor blocker. Finally, the increase in heat production instigated by nesfatin-1 promotes a reduction in body weight (p<0.05), which exhibits a prolonged duration even after overnight ad libitum access to food. Altogether, we herein provide evidence that the increase in energy expenditure instigated by nesfatin-1 is a process mediated via the central melanocortin system that in turn sets off iBAT thermogenesis, ultimately leading to a reduction in body mass. Centrally acting nesfatin-1 instigates catabolic effects.